On the one hand, we highlight the deployment of various strategies of pharmaceutical marketing for ADHD in Argentina, which are not aimed at the physician as the main recipient, and on the other hand, its incidence in the advocacy groups in Brazil.
Por una parte, resaltamos el despliegue de diversas estrategias de marketing farmacéutico para el TDAH en Argentina, que no se orientan al médico como principal destinatario, y por otra, su incidencia en los grupos de apoyo en Brasil.